Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Vitanova Biomedical
company
About
Vitanova Biomedical is an early-stage biotechnology company focused on delivering transformative cancer therapy.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $225K
- Industries
- Biotechnology,Health Care,Therapeutics,Wellness
- Founded date
- Jan 1, 2015
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Vitanova Biomedical is an early-stage biotechnology company focused on delivering transformative cancer therapy with the use of Light-Activated Intracellular Acidosis.The company aims to improve the lives of cancer patients and the professionals who care for them by providing cost-effective and efficacious cancer therapy that eliminates side effects. It was founded in 2015 by Matt Gdovin and Greg Espenhover in Kerrville, Texas in 2015.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$225K
Vitanova Biomedical has raised a total of
$225K
in funding over 2 rounds. Their latest funding was raised on
Aug 27, 2020 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 27, 2020 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Vitanova Biomedical is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
